The company was founded in 1926 and is one of the four earliest western medicine factories in China. Since 1982, Minsheng, as China's earliest national western medicine pharmaceutical company, has been focusing on the pharmaceutical industry and has witnessed the entire history of western medicine pharmaceuticals in China.

Based on raw materials and focusing on pharmaceutical preparations, the company develops and produces high-tech, high value-added products. It produces a variety of pharmaceutical raw materials and four major categories of pharmaceutical preparations all year round. All production varieties and facilities are It has passed GMP certification, and three API products have passed the US FDA certification. 21 Jinvita was recognized as a "China Famous Trademark" in 2004, and has established itself as a leading brand among similar products in China. The company enjoys a high reputation in the fields of anti-tumor and cardiovascular diseases. In 2006, it began to focus on the development of products in the field of anti-liver disease. 82 years of accumulation and development have equipped Minsheng Pharmaceutical with the basic conditions for modern pharmaceuticals. It has been identified by the relevant departments of the Hangzhou Municipal Government as a high-tech enterprise as a research and production base for high-efficiency chemical raw materials and various types of preparations.